GCC Generic Injectables Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
The GCC generic injectables market size reached US$ 607.8 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,245.4 Million by 2028, exhibiting a growth rate (CAGR) of 13.4% during 2023-2028.
Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use. They are used for treating a wide array of life-threatening and chronic diseases including diabetes, cancer, cardiovascular diseases, rheumatoid arthritis, respiratory diseases and osteoporosis. A rise in the prevalence of various lifestyle diseases in the GCC region has catalyzed the demand for these injectables. The lower cost of these drugs as compared to their branded equivalents further helps in providing substantial savings for the patients and healthcare providers.
Market Drivers:
An increase in the emigrant population along with a rise in the cases of both acute and chronic diseases has challenged the capability of the existing healthcare resources in the region. The resulting surge in the overall healthcare costs has boosted the demand for these injectables. Moreover, upcoming patent expiry of a number of blockbuster drugs prescribed in key therapeutic areas is expected to help in expanding the product portfolio of generic injectable manufacturers. Apart from this, the total number of manufacturers in the market is lower as compared to those in the oral generics segment. This results in lower price erosion and significantly higher margins. Some of the other factors driving the market in this region include aging population, development of the private healthcare sector and improving standards of living.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC generic injectables market report, along with forecasts at the regional and country level from 2023-2028. Our report has categorized the market based on container type, therapeutic area and distribution channel.
Breakup by Container Type:
Vials
Prefilled Syringes
Ampoules
Premix
Others
Vials account for the majority of the total market as they are compact in size, can be reused and are graduated with markings.
Breakup by Therapeutic Area:
Oncology
Anaesthesia
Anti-infectives
Cardiovascular
Parenteral Nutrition
Others
Currently, oncology represents the most popular therapeutic area on account of a rise in cancer diagnosis coupled with improved access to treatment.
Breakup by Distribution Channel:
Hospitals
Clinics
Retail Pharmacy Stores
These injectables are majorly distributed through hospitals as they cannot be traded or administered without medical assistance.
Regional Insights:
Saudi Arabia
UAE
Kuwait
Qatar
Oman
Bahrain
Saudi Arabia represents the leading market within the region. The manufacturers in the country are consistently collaborating with key pharma players for expanding their production capacity.
Competitive Landscape:
The competitive landscape of the market has also been analyzed in the report along with the profiles of key players.
Key Questions Answered in This Report:
How has the GCC generic injectables market performed so far and how will it perform in the coming years?
What are the key regional markets in the GCC generic injectables industry?
What has been the impact of COVID-19 on the GCC generic injectables market?
What are the several therapeutic areas in the GCC generic injectables industry?
What are the major distribution channels in the GCC generic injectables industry?
What are the different container types in the GCC generic injectables industry?
What are the various stages in the value chain of the GCC generic injectables industry?
What are the key driving factors and challenges in the GCC generic injectables industry?
What is the structure of the GCC generic injectables industry and who are the key players?
What is the degree of competition in the GCC generic injectables industry?
What are the profit margins in the GCC generic injectables industry?
What are the key requirements for setting up a generic injectables manufacturing plant?
How are generic injectables manufactured?
What are the various unit operations involved in a generic injectables manufacturing plant?
What is the total size of land required for setting up a generic injectables manufacturing plant?
What are the machinery requirements for setting up a generic injectables manufacturing plant?
What are the raw material requirements for setting up a generic injectables manufacturing plant?
What are the packaging requirements for generic injectables?
What are the transportation requirements for generic injectables?
What are the utility requirements for setting up a generic injectables manufacturing plant?
What are the manpower requirements for setting up a generic injectables manufacturing plant?
What are the capital costs for setting up a generic injectables manufacturing plant?
Generic injectables are equivalents of brand-name injectables with respect to quality, dosage, route of administration, performance, strength and intended use. They are used for treating a wide array of life-threatening and chronic diseases including diabetes, cancer, cardiovascular diseases, rheumatoid arthritis, respiratory diseases and osteoporosis. A rise in the prevalence of various lifestyle diseases in the GCC region has catalyzed the demand for these injectables. The lower cost of these drugs as compared to their branded equivalents further helps in providing substantial savings for the patients and healthcare providers.
Market Drivers:
An increase in the emigrant population along with a rise in the cases of both acute and chronic diseases has challenged the capability of the existing healthcare resources in the region. The resulting surge in the overall healthcare costs has boosted the demand for these injectables. Moreover, upcoming patent expiry of a number of blockbuster drugs prescribed in key therapeutic areas is expected to help in expanding the product portfolio of generic injectable manufacturers. Apart from this, the total number of manufacturers in the market is lower as compared to those in the oral generics segment. This results in lower price erosion and significantly higher margins. Some of the other factors driving the market in this region include aging population, development of the private healthcare sector and improving standards of living.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC generic injectables market report, along with forecasts at the regional and country level from 2023-2028. Our report has categorized the market based on container type, therapeutic area and distribution channel.
Breakup by Container Type:
Vials
Prefilled Syringes
Ampoules
Premix
Others
Vials account for the majority of the total market as they are compact in size, can be reused and are graduated with markings.
Breakup by Therapeutic Area:
Oncology
Anaesthesia
Anti-infectives
Cardiovascular
Parenteral Nutrition
Others
Currently, oncology represents the most popular therapeutic area on account of a rise in cancer diagnosis coupled with improved access to treatment.
Breakup by Distribution Channel:
Hospitals
Clinics
Retail Pharmacy Stores
These injectables are majorly distributed through hospitals as they cannot be traded or administered without medical assistance.
Regional Insights:
Saudi Arabia
UAE
Kuwait
Qatar
Oman
Bahrain
Saudi Arabia represents the leading market within the region. The manufacturers in the country are consistently collaborating with key pharma players for expanding their production capacity.
Competitive Landscape:
The competitive landscape of the market has also been analyzed in the report along with the profiles of key players.
Key Questions Answered in This Report:
How has the GCC generic injectables market performed so far and how will it perform in the coming years?
What are the key regional markets in the GCC generic injectables industry?
What has been the impact of COVID-19 on the GCC generic injectables market?
What are the several therapeutic areas in the GCC generic injectables industry?
What are the major distribution channels in the GCC generic injectables industry?
What are the different container types in the GCC generic injectables industry?
What are the various stages in the value chain of the GCC generic injectables industry?
What are the key driving factors and challenges in the GCC generic injectables industry?
What is the structure of the GCC generic injectables industry and who are the key players?
What is the degree of competition in the GCC generic injectables industry?
What are the profit margins in the GCC generic injectables industry?
What are the key requirements for setting up a generic injectables manufacturing plant?
How are generic injectables manufactured?
What are the various unit operations involved in a generic injectables manufacturing plant?
What is the total size of land required for setting up a generic injectables manufacturing plant?
What are the machinery requirements for setting up a generic injectables manufacturing plant?
What are the raw material requirements for setting up a generic injectables manufacturing plant?
What are the packaging requirements for generic injectables?
What are the transportation requirements for generic injectables?
What are the utility requirements for setting up a generic injectables manufacturing plant?
What are the manpower requirements for setting up a generic injectables manufacturing plant?
What are the capital costs for setting up a generic injectables manufacturing plant?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GCC GENERIC INJECTABLES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Region
5.5 Market Breakup by Therapeutic Area
5.6 Market Breakup by Container Type
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Research and Development
5.10.2 Manufacturing
5.10.3 Marketing and Distribution
5.11 Porter’s Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Supplier
5.11.3 Bargaining Power of Buyers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Price Analysis
5.12.1 Key Price Indicators
5.12.2 Price Structure
5.12.3 Margin Analysis
5.13 Key Market Drivers and Success Factors
6 MARKET PERFORMANCE BY KEY REGIONS
6.1 Saudi Arabia
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 UAE
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Kuwait
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Qatar
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Oman
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Bahrain
6.6.1 Market Trends
6.6.2 Market Forecast
7 MARKET PERFORMANCE BY CONTAINER TYPE
7.1 Vials
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Prefilled Syringes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ampoules
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Premix
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET PERFORMANCE BY THERAPEUTIC AREA
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Anaesthesia
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Anti-infectives
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiovascular
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Parenteral Nutrition
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 MARKET PERFORMANCE BY DISTRIBUTION CHANNEL
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Retail Pharmacy Stores
9.3.1 Market Trends
9.3.2 Market Forecast
10 COMPETITIVE LANDSCAPE
10.1 Market Structure
10.2 Key Players
11 GENERIC INJECTABLE MANUFACTURING PROCESS
11.1 Product Overview
11.2 Detailed Process Flow
11.3 Various Types of Unit Operations Involved
11.4 Mass Balance and Raw Material Requirements
12 PROJECT DETAILS, REQUIREMENTS AND COSTS INVOLVED
12.1 Land, Location and Site Development
12.2 Construction Requirements
12.3 Machinery Requirements
12.4 Machinery Pictures
12.5 Raw Material Requirements
12.6 Raw Material and Final Product Pictures
12.7 Packaging Requirements
12.8 Transportation Requirements
12.9 Utility Requirements
12.10 Manpower Requirements
12.11 Other Capital Investments
13 KEY PLAYER PROFILES
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GCC GENERIC INJECTABLES MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Region
5.5 Market Breakup by Therapeutic Area
5.6 Market Breakup by Container Type
5.7 Market Breakup by Distribution Channel
5.8 Market Forecast
5.9 SWOT Analysis
5.9.1 Overview
5.9.2 Strengths
5.9.3 Weaknesses
5.9.4 Opportunities
5.9.5 Threats
5.10 Value Chain Analysis
5.10.1 Research and Development
5.10.2 Manufacturing
5.10.3 Marketing and Distribution
5.11 Porter’s Five Forces Analysis
5.11.1 Overview
5.11.2 Bargaining Power of Supplier
5.11.3 Bargaining Power of Buyers
5.11.4 Degree of Competition
5.11.5 Threat of New Entrants
5.11.6 Threat of Substitutes
5.12 Price Analysis
5.12.1 Key Price Indicators
5.12.2 Price Structure
5.12.3 Margin Analysis
5.13 Key Market Drivers and Success Factors
6 MARKET PERFORMANCE BY KEY REGIONS
6.1 Saudi Arabia
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 UAE
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Kuwait
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Qatar
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Oman
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Bahrain
6.6.1 Market Trends
6.6.2 Market Forecast
7 MARKET PERFORMANCE BY CONTAINER TYPE
7.1 Vials
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Prefilled Syringes
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Ampoules
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Premix
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 MARKET PERFORMANCE BY THERAPEUTIC AREA
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Anaesthesia
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Anti-infectives
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Cardiovascular
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Parenteral Nutrition
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 MARKET PERFORMANCE BY DISTRIBUTION CHANNEL
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Clinics
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Retail Pharmacy Stores
9.3.1 Market Trends
9.3.2 Market Forecast
10 COMPETITIVE LANDSCAPE
10.1 Market Structure
10.2 Key Players
11 GENERIC INJECTABLE MANUFACTURING PROCESS
11.1 Product Overview
11.2 Detailed Process Flow
11.3 Various Types of Unit Operations Involved
11.4 Mass Balance and Raw Material Requirements
12 PROJECT DETAILS, REQUIREMENTS AND COSTS INVOLVED
12.1 Land, Location and Site Development
12.2 Construction Requirements
12.3 Machinery Requirements
12.4 Machinery Pictures
12.5 Raw Material Requirements
12.6 Raw Material and Final Product Pictures
12.7 Packaging Requirements
12.8 Transportation Requirements
12.9 Utility Requirements
12.10 Manpower Requirements
12.11 Other Capital Investments
13 KEY PLAYER PROFILES
LIST OF TABLES
Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2022 and 2028
Table 2: GCC: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 3: GCC: Generic Injectables Market Forecast: Breakup by Container Type (in Million US$), 2023-2028
Table 4: GCC: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 5: GCC: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: GCC: Generic Injectables Industry: Competitive Structure
Table 7: GCC: Generic Injectables Market: Key Players
Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2022 and 2028
Table 2: GCC: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 3: GCC: Generic Injectables Market Forecast: Breakup by Container Type (in Million US$), 2023-2028
Table 4: GCC: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2023-2028
Table 5: GCC: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
Table 6: GCC: Generic Injectables Industry: Competitive Structure
Table 7: GCC: Generic Injectables Market: Key Players
LIST OF FIGURES
Figure 1: GCC: Generic Injectables Market: Major Drivers and Challenges
Figure 2: GCC: Generic Injectables Market: Sales Value (in Million US$), 2017-2022
Figure 3: GCC: Generic Injectables Market: Breakup by Region (in %), 2022
Figure 4: GCC: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2022
Figure 5: GCC: Generic Injectables Market: Breakup by Container Type (in %), 2022
Figure 6: GCC: Generic Injectables Market: Breakup by Distribution Channel (in %), 2022
Figure 7: GCC: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 8: GCC: Generic Injectables Industry: SWOT Analysis
Figure 9: GCC: Generic Injectables Industry: Value Chain Analysis
Figure 10: GCC: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 11: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Saudi Arabia: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: UAE: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: UAE: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Kuwait: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Qatar: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Oman: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Oman: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Bahrain: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: GCC: Generic Injectables (in Vials) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: GCC: Generic Injectables (in Vials) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: GCC: Generic Injectables (in Prefilled Syringes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: GCC: Generic Injectables (in Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: GCC: Generic Injectables (in Ampoules) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: GCC: Generic Injectables (in Ampoules) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: GCC: Generic Injectables (in Premix) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: GCC: Generic Injectables (in Premix) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: GCC: Generic Injectables (in Other Container Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: GCC: Generic Injectables (in Other Container Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: GCC: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: GCC: Generic Injectables (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: GCC: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: GCC: Generic Injectables (Anaesthesia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: GCC: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: GCC: Generic Injectables (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: GCC: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: GCC: Generic Injectables (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: GCC: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: GCC: Generic Injectables (Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: GCC: Other Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: GCC: Other Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: GCC: Generic Injectables Market: Sales through Hospitals (in Million US$), 2017 & 2022
Figure 46: GCC: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2023-2028
Figure 47: GCC: Generic Injectables Market: Sales through Clinics (in Million US$), 2017 & 2022
Figure 48: GCC: Generic Injectables Market Forecast: Sales through Clinics (in Million US$), 2023-2028
Figure 49: GCC: Generic Injectables Market: Sales through Retail Pharmacy Stores (in Million US$), 2017 & 2022
Figure 50: GCC: Generic Injectables Market Forecast: Sales through Retail Pharmacy Stores (in Million US$), 2023-2028
Figure 51: Generic Injectables Manufacturing: Detailed Process Flow
Figure 52: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 53: Generic Oncology Drug Manufacturing Plant: Tertiary Packaging
Figure 54: Generic Injectables Manufacturing Process: Breakup of Capital Costs (in %)
Figure 55: Generic Injectables Industry: Breakup of Profit Margins at Various Level of the Value Chain
Figure 1: GCC: Generic Injectables Market: Major Drivers and Challenges
Figure 2: GCC: Generic Injectables Market: Sales Value (in Million US$), 2017-2022
Figure 3: GCC: Generic Injectables Market: Breakup by Region (in %), 2022
Figure 4: GCC: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2022
Figure 5: GCC: Generic Injectables Market: Breakup by Container Type (in %), 2022
Figure 6: GCC: Generic Injectables Market: Breakup by Distribution Channel (in %), 2022
Figure 7: GCC: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 8: GCC: Generic Injectables Industry: SWOT Analysis
Figure 9: GCC: Generic Injectables Industry: Value Chain Analysis
Figure 10: GCC: Generic Injectables Industry: Porter’s Five Forces Analysis
Figure 11: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Saudi Arabia: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: UAE: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: UAE: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Kuwait: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Qatar: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Oman: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Oman: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Bahrain: Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: GCC: Generic Injectables (in Vials) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: GCC: Generic Injectables (in Vials) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: GCC: Generic Injectables (in Prefilled Syringes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: GCC: Generic Injectables (in Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: GCC: Generic Injectables (in Ampoules) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: GCC: Generic Injectables (in Ampoules) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: GCC: Generic Injectables (in Premix) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: GCC: Generic Injectables (in Premix) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: GCC: Generic Injectables (in Other Container Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: GCC: Generic Injectables (in Other Container Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: GCC: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: GCC: Generic Injectables (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: GCC: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: GCC: Generic Injectables (Anaesthesia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: GCC: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: GCC: Generic Injectables (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: GCC: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: GCC: Generic Injectables (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: GCC: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: GCC: Generic Injectables (Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: GCC: Other Generic Injectables Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: GCC: Other Generic Injectables Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: GCC: Generic Injectables Market: Sales through Hospitals (in Million US$), 2017 & 2022
Figure 46: GCC: Generic Injectables Market Forecast: Sales through Hospitals (in Million US$), 2023-2028
Figure 47: GCC: Generic Injectables Market: Sales through Clinics (in Million US$), 2017 & 2022
Figure 48: GCC: Generic Injectables Market Forecast: Sales through Clinics (in Million US$), 2023-2028
Figure 49: GCC: Generic Injectables Market: Sales through Retail Pharmacy Stores (in Million US$), 2017 & 2022
Figure 50: GCC: Generic Injectables Market Forecast: Sales through Retail Pharmacy Stores (in Million US$), 2023-2028
Figure 51: Generic Injectables Manufacturing: Detailed Process Flow
Figure 52: Generic Injectables Manufacturing Process: Conversion Rate of Feedstocks
Figure 53: Generic Oncology Drug Manufacturing Plant: Tertiary Packaging
Figure 54: Generic Injectables Manufacturing Process: Breakup of Capital Costs (in %)
Figure 55: Generic Injectables Industry: Breakup of Profit Margins at Various Level of the Value Chain
